ES2087623T3 - Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. - Google Patents

Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.

Info

Publication number
ES2087623T3
ES2087623T3 ES93113149T ES93113149T ES2087623T3 ES 2087623 T3 ES2087623 T3 ES 2087623T3 ES 93113149 T ES93113149 T ES 93113149T ES 93113149 T ES93113149 T ES 93113149T ES 2087623 T3 ES2087623 T3 ES 2087623T3
Authority
ES
Spain
Prior art keywords
bencimidazole
pylon
derivatives
antimicrobial agent
agent against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93113149T
Other languages
English (en)
Inventor
Masaru Sato
Shigeru Souda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2087623T3 publication Critical patent/ES2087623T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS COMPUESTOS QUE TIENEN LA SIGUIENTE FORMULA (I) EN LA QUE N ES 0 O 1; O SALES FARMACEUTICAMENTE ACEPTABLES DE ESTOS PUEDEN SER USADAS PARA LA PREPARACION DE UN MEDICAMENTO PARA PREVENIR ,MEJORAR Y TRATAR UNA ENFERMEDAD CAUSADA POR LA BACTERIA CAMPYLOBACTER PYLORI, EN PARTICULAR ULCERA PEPTICA O GASTRITIS O ENFERMEDADES INFECCIOSAS, Y PARA ERRADICAR LA BACTERIA CAMPYLOBACTER PYLORI DE LA MEMBRANA DE LAS MUCOSAS DE UN PACIENTE Y PREVENIR LA RECURRENCIA DE UNA ENFERMEDAD CAUSADA POR CAMPYLOBACTER PYLORI.
ES93113149T 1992-08-21 1993-08-17 Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. Expired - Lifetime ES2087623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24404292 1992-08-21

Publications (1)

Publication Number Publication Date
ES2087623T3 true ES2087623T3 (es) 1996-07-16

Family

ID=17112856

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93113149T Expired - Lifetime ES2087623T3 (es) 1992-08-21 1993-08-17 Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.

Country Status (10)

Country Link
US (1) US5916904A (es)
EP (1) EP0585722B1 (es)
AT (1) ATE137969T1 (es)
CA (1) CA2104531C (es)
DE (1) DE69302646T2 (es)
DK (1) DK0585722T3 (es)
ES (1) ES2087623T3 (es)
FI (1) FI933681A7 (es)
GR (1) GR3019917T3 (es)
NO (1) NO307689B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
CA2317439A1 (en) * 1998-01-14 1999-07-22 Wayne J. Brouillette Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6861448B2 (en) 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
ATE256677T1 (de) * 1998-08-25 2004-01-15 Uab Research Foundation Inhibitoren der bakteriellen nad synthetase
US6174902B1 (en) 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US7608625B2 (en) * 2003-03-13 2009-10-27 Eisai R & D Management Co., Ltd. Method for treating bruxism and bruxism-related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2066120T3 (es) * 1989-02-10 1995-03-01 Takeda Chemical Industries Ltd Uso de derivados de bencimidazol como agentes antibacterianos.
JPH0348680A (ja) * 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
DK0585722T3 (da) 1996-08-05
CA2104531A1 (en) 1994-02-22
DE69302646D1 (de) 1996-06-20
FI933681A0 (fi) 1993-08-20
GR3019917T3 (en) 1996-08-31
DE69302646T2 (de) 1996-10-31
ATE137969T1 (de) 1996-06-15
NO307689B1 (no) 2000-05-15
FI933681L (fi) 1994-02-22
US5916904A (en) 1999-06-29
CA2104531C (en) 1999-01-05
NO932947L (no) 1994-02-22
NO932947D0 (no) 1993-08-19
FI933681A7 (fi) 1994-02-22
EP0585722B1 (en) 1996-05-15
EP0585722A1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
ES2155473T3 (es) Composicion veterinaria que contiene un inhibidor de las bombas de protones.
ES2086270T3 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
BR9611015A (pt) Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2157005T3 (es) Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina.
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
BR0014895A (pt) Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
ES2091183T3 (es) Metodo para mejorar el sueño.
ES2149403T3 (es) Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2038216T3 (es) Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo.
MX9400040A (es) Composiciones para tratar trastornos respiratorios.
MX173156B (es) Composiciones para tratar o evitar la placa dental o enfermedades gingivales o periodontales de la cavidad oral en humanos o animales inferiores
BR0115215A (pt) Método para o tratamento de inflamações
MC2142A1 (fr) Medicament contre la toxoplasmose
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
AR005724A1 (es) Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0585722

Country of ref document: ES